4.5 Letter

COVID-19 pandemic is not the time of trial and error

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Letter Gastroenterology & Hepatology

Global prediction of primary liver cancer incidences and mortality in 2040

Chenxi Li et al.

JOURNAL OF HEPATOLOGY (2023)

Review Medicine, Research & Experimental

The urgent need for integrated science to fight COVID-19 pandemic and beyond

Negar Moradian et al.

JOURNAL OF TRANSLATIONAL MEDICINE (2020)

Review Medical Laboratory Technology

COVID-19: Transmission, prevention, and potential therapeutic opportunities

Melika Lotfi et al.

CLINICA CHIMICA ACTA (2020)

Review Biotechnology & Applied Microbiology

Drug repurposing: progress, challenges and recommendations

Sudeep Pushpakom et al.

NATURE REVIEWS DRUG DISCOVERY (2019)

Article Oncology

Adapalene inhibits the activity of cyclin-dependent kinase 2 in colorectal carcinoma

Xi-Nan Shi et al.

MOLECULAR MEDICINE REPORTS (2015)

Article Cell Biology

In silico identification of potential targets and drugs for non-small cell lung cancer

Chien-Hung Huang et al.

IET SYSTEMS BIOLOGY (2014)

Review Biochemistry & Molecular Biology

Recent Advances in Drug Repositioning for the Discovery of New Anticancer Drugs

Joong Sup Shim et al.

INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2014)

Review Pharmacology & Pharmacy

Novel Computational Approaches to Polypharmacology as a Means to Define Responses to Individual Drugs

Lei Xie et al.

ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 52 (2012)

Review Pharmacology & Pharmacy

Multi-target therapeutics: when the whole is greater than the sum of the parts

Grant R. Zimmermann et al.

DRUG DISCOVERY TODAY (2007)